| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | EMTRICITABINE, RILPIVIRINE HYDROCHLORIDE, AND TENOFOVIR DISOPROXIL FUMARATE | 3560 | 0.5291 |
| 1 | ELVITEGRAVIR, COBICISTAT, EMTRICITABINE, AND TENOFOVIR DISOPROXIL FUMARATE | 4603 | 0.5133 |
| 2 | TRIAMCINOLONE HEXACETONIDE | 133 | 0.5076 |
| 3 | ELVITEGRAVIR, COBICISTAT, EMTRICITABINE, AND TENOFOVIR ALAFENAMIDE | 4545 | 0.4525 |
| 4 | EMTRICITABINE, RILPIVIRINE HYDROCHLORIDE, AND TENOFOVIR ALAFENAMIDE | 1605 | 0.4463 |
| 5 | EMTRICITABINE AND TENOFOVIR ALAFENAMIDE | 4869 | 0.4263 |
| 6 | DARUNAVIR, COBICISTAT, EMTRICITABINE, AND TENOFOVIR ALAFENAMIDE | 1067 | 0.3874 |
| 7 | EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE | 16618 | 0.3658 |
| 8 | DARUNAVIR ETHANOLATE AND COBICISTAT | 170 | 0.0965 |
| 9 | RALTEGRAVIR | 319 | 0.0608 |
| # | Drug class | Count |
|---|---|---|
| 0 | Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 20926 |
| 1 | Cytochrome P450 3A Inhibitor [EPC] | 8565 |
| 2 | Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor [EPC] | 7270 |
| 3 | Nonsteroidal Anti-inflammatory Drug [EPC] | 1972 |
| 4 | Protease Inhibitor [EPC] | 1807 |
| 5 | Corticosteroid [EPC] | 1748 |
| 6 | Parathyroid Hormone Analog [EPC] | 1714 |
| 7 | RANK Ligand Inhibitor [EPC] | 1190 |
| 8 | Provitamin D2 Compound [EPC] | 988 |
| 9 | Calcium [EPC] | 830 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 20926 | 0.1899 |
| 1 | Cytochrome P450 3A Inhibitor [EPC] | 8565 | 0.1417 |
| 2 | Protease Inhibitor [EPC] | 1807 | 0.0406 |
| 3 | Provitamin D2 Compound [EPC] | 988 | 0.0332 |
| 4 | Interleukin-5 Antagonist [EPC] | 22 | 0.0320 |
| 5 | Interleukin-1 Receptor Antagonist [EPC] | 387 | 0.0229 |
| 6 | Calcitonin [EPC] | 59 | 0.0189 |
| 7 | Antidiarrheal [EPC] | 4 | 0.0167 |
| 8 | Parathyroid Hormone Analog [EPC] | 1714 | 0.0152 |
| 9 | CCR5 Co-receptor Antagonist [EPC] | 33 | 0.0144 |